125 related articles for article (PubMed ID: 38528486)
1. Comment on "A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer".
Chehelgerdi M; Khorramian-Ghahfarokhi M; Dehkordi FB; Chehelgerdi M
BMC Cancer; 2024 Mar; 24(1):377. PubMed ID: 38528486
[TBL] [Abstract][Full Text] [Related]
2. A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer.
Wu Q; Tao X; Luo Y; Zheng S; Lin N; Xie X
BMC Cancer; 2023 Aug; 23(1):776. PubMed ID: 37596527
[TBL] [Abstract][Full Text] [Related]
3. NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer.
Di Benedetto C; Oh J; Choudhery Z; Shi W; Valdes G; Betancur P
BMC Cancer; 2022 Oct; 22(1):1056. PubMed ID: 36224576
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.
Li J; Wu J; Han J
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672784
[TBL] [Abstract][Full Text] [Related]
5. Senescence-related genes analysis in breast cancer reveals the immune microenvironment and implications for immunotherapy.
Zhong H; Chang L; Pei S; Kang Y; Yang L; Wu Y; Chen N; Luo Y; Zhou Y; Xie J; Xia Y
Aging (Albany NY); 2024 Feb; 16(4):3531-3553. PubMed ID: 38358910
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer.
Chang X; Xing P
Lipids Health Dis; 2022 May; 21(1):43. PubMed ID: 35562758
[TBL] [Abstract][Full Text] [Related]
7. Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment.
Zhou N; Kong D; Lin Q; Yang X; Zhou D; Lou L; Huang F
Cancer Genet; 2023 Aug; 276-277():17-29. PubMed ID: 37343507
[TBL] [Abstract][Full Text] [Related]
8. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
9. A zinc metabolism-related gene signature for predicting prognosis and characteristics of breast cancer.
Hong J; Li M; Chen Y; Du Y; Song D
Front Immunol; 2023; 14():1276280. PubMed ID: 38259456
[TBL] [Abstract][Full Text] [Related]
10. Prognosis and Dissection of Immunosuppressive Microenvironment in Breast Cancer Based on Fatty Acid Metabolism-Related Signature.
Tang Y; Tian W; Xie J; Zou Y; Wang Z; Li N; Zeng Y; Wu L; Zhang Y; Wu S; Xie X; Yang L
Front Immunol; 2022; 13():843515. PubMed ID: 35432381
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
12. Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
Tan W; Liu M; Wang L; Guo Y; Wei C; Zhang S; Luo C; Liu N
BMC Cancer; 2021 Feb; 21(1):126. PubMed ID: 33549054
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
Song S; Zhang M; Xie P; Wang S; Wang Y
Front Immunol; 2022; 13():978909. PubMed ID: 36341328
[TBL] [Abstract][Full Text] [Related]
14. A CD8
Lv LH; Lu JR; Zhao T; Liu JL; Liang HQ
J Mammary Gland Biol Neoplasia; 2022 Mar; 27(1):53-65. PubMed ID: 35088220
[TBL] [Abstract][Full Text] [Related]
15. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
Liang J; Wang X; Yang J; Sun P; Sun J; Cheng S; Liu J; Ren Z; Ren M
Front Immunol; 2023; 14():1198826. PubMed ID: 38035071
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression.
Yang Z; Zheng Y; Wu H; Xie H; Zhao J; Chen Z; Li L; Yue X; Zhao B; Bian E
Hum Genomics; 2023 Mar; 17(1):33. PubMed ID: 37004060
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer.
Liu Z; Ding M; Qiu P; Pan K; Guo Q
Front Immunol; 2023; 14():1200282. PubMed ID: 37520534
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
[TBL] [Abstract][Full Text] [Related]
19. An angiogenesis-related lncRNA signature predicts the immune microenvironment and prognosis of breast cancer.
Wang YW; Liu C; Chen YD; Yang B; Chen X; Ma G; Tian YR; Bo X; Zhang K
Aging (Albany NY); 2023 Aug; 15(15):7616-7636. PubMed ID: 37543427
[TBL] [Abstract][Full Text] [Related]
20. The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma.
Hu Y; Yang Q; Cai S; Wang W; Fu S
Front Genet; 2023; 14():1085584. PubMed ID: 37091789
[No Abstract] [Full Text] [Related]
[Next] [New Search]
